Vaccination: Clinical Trials

Department of Health and Social Care written question – answered at on 14 February 2024.

Alert me about debates like this

Photo of Baroness Ritchie of Downpatrick Baroness Ritchie of Downpatrick Non-affiliated

To ask His Majesty's Government what assessment they have made of the number and diversity of vaccines proceeding through clinical trials, and the resources that will be required to assess their clinical and cost effectiveness in a timely manner.

Photo of Lord Markham Lord Markham The Parliamentary Under-Secretary for Health and Social Care

As part of its horizon scanning work, the Department works closely with the Joint Committee on Vaccination and Immunisation to stay abreast of vaccines under development and to factor them into future planning and prioritisation work as appropriate. This includes consideration of the expert and analytical resource that will be required to assess their effectiveness, both clinical and cost. The Medicines and Healthcare products Regulatory Agency also plays a role in considering vaccines proceeding through clinical trials and considers them for licensing as they become ready.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.